Multiple sclerosis and gait impairment: moving from the subjective to the objective - Measurement as markers for disease progression

被引：0
|
作者：
Gudesblatt, M.
Lamberg, E.
McKenna, R.
Zarif, M.
Burke, C.
Bumstead, B.
Buhse, M.
Fafard, L.
Muratori, L.
机构：
[1] South Shore Neurol Associates, Patchogue, NY USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Patchogue, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] ASSESSMENT OF THE NEUROLOGICAL IMPAIRMENT AND PROGRESSION IN MULTIPLE-SCLEROSIS
    CENDROWSKI, W
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 229 - 233
  • [42] Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis
    Gencer, Mehmet
    Akbayir, Ece
    Sen, Melis
    Arsoy, Erdil
    Yilmaz, Vuslat
    Bulut, Nesrin
    Tuzun, Erdem
    Turkoglu, Recai
    NEUROLOGICAL SCIENCES, 2019, 40 (05) : 1067 - 1070
  • [43] Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis
    Mehmet Gencer
    Ece Akbayır
    Melis Şen
    Erdil Arsoy
    Vuslat Yılmaz
    Nesrin Bulut
    Erdem Tüzün
    Recai Türkoğlu
    Neurological Sciences, 2019, 40 : 1067 - 1070
  • [44] Longitudinal assessment of balance impairment in multiple sclerosis identify patients with silent disease progression
    Mancuso, E.
    Boffa, G.
    Boccia, D.
    Tazza, F.
    Lapucci, C.
    Sbragia, E.
    Cellerino, M.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 198 - 199
  • [45] Multiple markers contribute to risk of progression from normal to mild cognitive impairment
    Rabin, Jennifer S.
    Neal, Taylor E.
    Nierle, Hannah E.
    Sikkes, Sietske A. M.
    Buckley, Rachel F.
    Amariglio, Rebecca E.
    Papp, Kathryn V.
    Rentz, Dorene M.
    Schultz, Aaron P.
    Johnson, Keith A.
    Sperling, Reisa A.
    Hedden, Trey
    NEUROIMAGE-CLINICAL, 2020, 28
  • [46] Smoking and Disease Progression in Multiple Sclerosis
    Healy, Brian C.
    Ali, Eman N.
    Guttmann, Charles R. G.
    Chitnis, Tanuja
    Glanz, Bonnie I.
    Buckle, Guy
    Houtchens, Maria
    Stazzone, Lynn
    Moodie, Jennifer
    Berger, Annika M.
    Duan, Yang
    Bakshi, Rohit
    Khoury, Samia
    Weiner, Howard
    Ascherio, Alberto
    ARCHIVES OF NEUROLOGY, 2009, 66 (07) : 858 - 864
  • [47] Neuropathology and disease progression in multiple sclerosis
    Bjartmar, C
    Trapp, BD
    EARLY INDICATORS, EARLY TREATMENTS, NEUROPROTECTION IN MULTIPLE SCLEROSIS, 2003, : 49 - 61
  • [48] Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
    Lourenco, Pedro
    Shirani, Afsaneh
    Saeedi, Jameelah
    Oger, Joel
    Schreiber, William E.
    Tremlett, Helen
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 577 - 584
  • [49] Hematological markers as prognostic indicators in multiple sclerosis progression
    Poursadeghfard, Maryam
    Shiati, Samin
    Salehi, Mohammad Saied
    Khani, Aryan
    Vafaeian, Soheil
    Bayat, Mahnaz
    Hooshmandi, Etrat
    BIOMARKERS IN MEDICINE, 2025, 19 (01) : 5 - 12
  • [50] Multiple sclerosis: CSF markers predict progression from radiologically isolated syndrome
    Fyfe I.
    Nature Reviews Neurology, 2018, 14 (4) : 194 - 194
12345